Sanuwave Health (SNWV)
(Delayed Data from NSDQ)
$28.94 USD
+0.92 (3.28%)
Updated Oct 31, 2025 03:59 PM ET
After-Market: $29.02 +0.08 (0.28%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth C Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
SNWV 28.94 +0.92(3.28%)
Will SNWV be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for SNWV based on the 1-3 month trading system that more than doubles the S&P 500.

Zacks News for SNWV
Sanuwave Health Inc. (SNWV) to Report Q3 Results: Wall Street Expects Earnings Growth
Sanuwave Health (SNWV) Surges 9.1%: Is This an Indication of Further Gains?
SNWV: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for SNWV
The technical outlook for SNWV is unchanged after it rises 3.28% on November 1
SNWV forms Directional Movement Crossover Bearish on October 30
Technical picture remains unchanged for SNWV after it falls 1.93% on October 30
Sanuwave Health Terminates President Andrew Walko
SNWV rises 0.06% on October 28, leaving the technical picture intact